Neuropsychological measures that detect early impairment and decline in preclinical Alzheimer disease

Identifying which neuropsychological measures detect early cognitive changes associated with Alzheimer disease (AD) brain pathology would be helpful clinically for the diagnosis of early AD and for the design of clinical trials. We evaluated which neuropsychological measures in our cognitive battery...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neurobiol Aging
Päätekijät: Schindler, Suzanne E., Jasielec, Mateusz S., Weng, Hua, Hassenstab, Jason J., Grober, Ellen, McCue, Lena M., Morris, John C., Holtzman, David M., Xiong, Chengjie, Fagan, Anne M.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2017
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5505233/
https://ncbi.nlm.nih.gov/pubmed/28482211
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neurobiolaging.2017.04.004
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia